Terms: = Germ cell tumor AND PTPRK, DKFZp686C2268, 5796, ENSG00000152894, DKFZp779N1045, R-PTP-kappa, RP3-480J14_1 AND Treatment
35948 results:
1. From decision to reflection: understanding the experiences and unmet care needs of patients treated with immunotherapy for melanoma in the adjuvant or metastatic setting.
Kamminga NCW; van der Veldt AAM; Wakkee M; van den Berge FR; van der Beek LAA; Joosen MCW; Joosse A; de Joode K; Nijsten TEC; Lugtenberg M
BMC Cancer; 2024 May; 24(1):662. PubMed ID: 38816701
[TBL] [Abstract] [Full Text] [Related]
2. Extracting Electronic Health Record Neuroblastoma treatment Data With High Fidelity Using the REDCap Clinical Data Interoperability Services Module.
Furner B; Cheng A; Desai AV; Benedetti DJ; Friedman DL; Wyatt KD; Watkins M; Volchenboum SL; Cohn SL
JCO Clin Cancer Inform; 2024 May; 8():e2400009. PubMed ID: 38815188
[TBL] [Abstract] [Full Text] [Related]
3. Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology.
Vince CSC; Brassesco MS; Mançano BM; Gregianin LJ; Carbone EK; do Amaral E Castro A; Dwan VSY; Menezes da Silva RZ; Mariano CS; da Mata JF; Silva MO; Caran EMM; Macedo CD; Alves da Costa G; Esteves TC; Silva LN; Ferman SE; Martins FD; Cristófani LM; Odone-Filho V; Silva MM; Reis RM; Pianovski MAD; Campregher PV; Kunii MS; de Sá Rodrigues KE; Carvalho Filho NP; Valera ET;
JCO Precis Oncol; 2024 May; 8():e2300713. PubMed ID: 38810175
[TBL] [Abstract] [Full Text] [Related]
4. A novel lateral myelotomy approach for the treatment of lateral or ventrolateral spinal gliomas.
Hang G; Gong Y; Xie H; Xie T
Acta Neurochir (Wien); 2024 May; 166(1):237. PubMed ID: 38809310
[TBL] [Abstract] [Full Text] [Related]
5. [Our experience in the treatment of congenital nasal median heterotopias in children and an overview of various treatment tactics].
Molodtsova EV; Yunusov AS; Daikhes NA; Polyakov DP; Korobkin AS; Larina OM
Vestn Otorinolaringol; 2024; 89(2):28-32. PubMed ID: 38805460
[TBL] [Abstract] [Full Text] [Related]
6. Optic nerve sheath diameter correlates with both success and failure of hydrocephalus treatment in pediatric patients with pineal region lesions.
Zipfel J; Kerscher SR; Dhillon K; Ferraris KP; Singhal A
Acta Neurochir (Wien); 2024 May; 166(1):236. PubMed ID: 38805061
[TBL] [Abstract] [Full Text] [Related]
7. Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological study.
Vissing M; Sinius Pouplier S; Munch Larsen L; Krog Frandsen S; Lodin A; Lænkholm AV; Gehl J
Acta Oncol; 2024 May; 63():398-410. PubMed ID: 38804839
[TBL] [Abstract] [Full Text] [Related]
8. Tumour growth rate predicts overall survival in patients with recurrent WHO grade 4 glioma.
Pang JHW; Saffari SE; Lee GR; Yu WY; Lim CCT; Lim KC; Lee CC; Koh WY; Chia WTD; Chua KLM; Tham CK; Low YYS; Ng WH; Low CYD; Lin X
BMC Med Imaging; 2024 May; 24(1):125. PubMed ID: 38802734
[TBL] [Abstract] [Full Text] [Related]
9. Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?
Squicciarini T; Villani R; Apollonio B; Fucci L; Zambetti M; Rossini M; Pinto R; Tommasi S; De Roma I; Strippoli S; Guida M
Front Immunol; 2024; 15():1369531. PubMed ID: 38799429
[TBL] [Abstract] [Full Text] [Related]
10. A radiomics-based nomogram may be useful for predicting telomerase reverse transcriptase promoter mutation status in adult glioblastoma.
Li Y; Chen L; Huang L; Li X; Huang Q; Tang L; Huang Z; Zhu L; Li T
Brain Behav; 2024 May; 14(5):e3528. PubMed ID: 38798094
[TBL] [Abstract] [Full Text] [Related]
11. [Neurofibromatosis type 1 associated with pheochromocytoma: a case report with a brief review of the literature].
Lugovskaya AY; Britvin TA; Gurevich LE; Rog IS; Nefedova LN; Ilovayskaya IA
Probl Endokrinol (Mosk); 2023 Sep; 70(2):53-64. PubMed ID: 38796761
[TBL] [Abstract] [Full Text] [Related]
12. Fluorescein-guided surgery in high-grade gliomas: focusing on the eloquent and deep-seated areas.
Xiao Y; Li M; Wang X; Tan J; Qin C; Liu Q
J Cancer Res Clin Oncol; 2024 May; 150(5):274. PubMed ID: 38795238
[TBL] [Abstract] [Full Text] [Related]
13. Autoimmune Encephalitis following Checkpoint Inhibitor Therapy in a Patient with Metastatic Melanoma in Complete Remission.
Civardi G; Medioli A; Braghieri C; Ambroggi M; Immovilli P; Orsucci S; Contini P; Aronica G; Cavanna L
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792910
[TBL] [Abstract] [Full Text] [Related]
14. Metabolic Contrasts: Fatty Acid Oxidation and Ketone Bodies in Healthy Brains vs. Glioblastoma Multiforme.
Tamas C; Tamas F; Kovecsi A; Cehan A; Balasa A
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791520
[TBL] [Abstract] [Full Text] [Related]
15. FOSL1's Oncogene Roles in Glioma/Glioma Stem cells and tumorigenesis: A Comprehensive Review.
Khedri A; Guo S; Ramar V; Hudson B; Liu M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791400
[TBL] [Abstract] [Full Text] [Related]
16. Brachytherapy in craniopharyngiomas: a systematic review and meta-analysis of long-term follow-up.
Zhang LY; Guo W; Du HZ; Pan H; Sun YC; Zhu HJ; Song SH; Guo XY; Jiang Y; Sun QQ
BMC Cancer; 2024 May; 24(1):637. PubMed ID: 38790011
[TBL] [Abstract] [Full Text] [Related]
17. Epidemiological characteristics of neuroendocrine neoplasms in Beijing: a population-based retrospective study.
Chi Y; Liu S; Zhang J; Li H; Yang L; Zhang X; Li H; Li Q; Wang N; Lu M; Zhuo M
BMC Public Health; 2024 May; 24(1):1396. PubMed ID: 38789981
[TBL] [Abstract] [Full Text] [Related]
18. Photodynamic therapy using talaporfin sodium for non-totally resectable malignant glioma.
Fukami S; Akimoto J; Nagai K; Saito Y; Kohno M
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103869. PubMed ID: 38787766
[TBL] [Abstract] [Full Text] [Related]
19. Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening.
Zhong Y; Le H; Zhang X; Dai Y; Guo F; Ran X; Hu G; Xie Q; Wang D; Cai Y
J Hematol Oncol; 2024 May; 17(1):36. PubMed ID: 38783389
[TBL] [Abstract] [Full Text] [Related]
20. Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab - study protocol.
Janssen JC; van Dijk B; de Joode K; Aarts MJB; van den Berkmortel FWPJ; Blank CU; Boers-Sonderen MJ; van den Eertwegh AJM; de Groot JWB; Jalving M; de Jonge MJA; Joosse A; Kapiteijn E; Kamphuis-Huismans AM; Naipal KAT; Piersma D; Rikhof B; Westgeest HM; Vreugdenhil G; Oomen-de Hoop E; Mulder EEAP; van der Veldt AAM
BMC Cancer; 2024 May; 24(1):632. PubMed ID: 38783238
[TBL] [Abstract] [Full Text] [Related]
[Next]
